ECCV
Eagle Point Credit Company Inc.
There isn't enough reported data to score ECCV yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ECCV Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
ECCV's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECCV.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ECCV PE Valuation
ECCV has no meaningful PE right now: it lost money over the past year.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ECCV Forward outlook
There aren't enough analyst estimates for ECCV to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ECCV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.24 | -1227% |
| Q1 2026 | -$1.29 | -$0.89 |
| Q4 2025 | -$0.98 | -217% |
| Q3 2025 | $0.26 | -67% |
| Q2 2025 | $0.11 | -93% |
| Q1 2025 | -$0.40 | -123% |
| Q4 2024 | $0.84 | -50% |
| Q3 2024 | $0.78 | -48% |
ECCV has swung to a loss: it lost $1.24 per share over the past year, after a profit the year before.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has the edge over ECCV on earnings, with more consistent year-over-year improvement.
ECCV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $31.4M | -45% |
| Q3 2025 | $52M | +10% |
| Q1 2025 | $57.7M | +41% |
| Q4 2024 | $49.5M | +26% |
| Q3 2024 | $47.1M | +31% |
| Q1 2024 | $40.8M | +32% |
| Q4 2023 | $39.4M | +21% |
| Q3 2023 | $36M | +19% |
ECCV's revenue has slid since its 2025 peak: −$63M last quarter, down 188% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -433% | -282 points |
| Q3 2025 | 75% | +1.5 points |
| Q2 2025 | 87% | N/A |
| Q1 2025 | -152% | -220 points |
| Q4 2024 | 65% | -7.4 points |
| Q3 2024 | 73% | +0.9 points |
| Q1 2024 | 69% | -9 points |
| Q4 2023 | 73% | -2.6 points |
ECCV's operating margin was −433% last quarter, down 498 points from the same quarter a year ago, near the bottom of its range since 2019.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ECCV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $34.8M | +17% |
| Q1 2026 | $29M | +6% |
| Q4 2025 | $30.3M | +24% |
| Q3 2025 | -$16.3M | -158% |
| Q2 2025 | $29.7M | +3.2% |
| Q1 2025 | $27.4M | +24% |
| Q4 2024 | $24.5M | +2% |
| Q3 2024 | $28.2M | +27% |
ECCV has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ECCV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +480K shares |
| 1 year | +11% | +12.8M shares |
| 3 years | +112% | +70.2M shares |
| 5 years | +286% | +98.5M shares |
| Available history | +390% | +106M shares |
ECCV has 133M diluted shares, up 11% from a year ago, despite $63M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $57.9M |
| Q1 2026 | $4.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ECCV spent $63M buying back its own shares over the past year, after none the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over ECCV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ECCV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 7.6x | High |
| Q2 2025 | 4.8x | High |
| Q1 2024 | 1.8x | Healthy |
| Q4 2023 | 1.1x | Healthy |
| Q3 2023 | 1.8x | Healthy |
| Q2 2023 | 1.2x | Healthy |
| Q1 2023 | 2.1x | Moderate |
| Q4 2022 | 1.1x | Healthy |
ECCV's net debt is about 7.6 years of its operating earnings (EBITDA), up from 1.8 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ECCV.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ECCV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.4 | Neutral |
| Stochastic | 43.3 | Neutral |
ECCV's weekly RSI is 52 (neutral) and its Stochastic is 43 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ECCV PE vs Financial Services Sector
| Metric | ECCV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ECCV has no meaningful PE right now: it lost money over the past year.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ECCV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.2 | 0.1% below |
| 20 week MA | $24.1 | 0.2% above |
| 50 week MA | $23.9 | 1.1% above |
| 100 week MA | $23.5 | 2.8% above |
| 200 week MA | $22.9 | 5.6% above |
ECCV has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ECCV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $24.3 | $21.0 | -13% |
| 2023 | $21.0 | $22.4 | +6.4% |
| 2024 | $22.4 | $22.7 | +1.6% |
| 2025 | $22.7 | $23.5 | +3.5% |
| 2026 YTD | $23.5 | $24.2 | +2.8% |
ECCV has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.